Showing 2 posts of 2 posts found.


Gilead and Jounce Therapeutics forge immuno-oncology partnership worth a potential $700m+

September 2, 2020
Research and Development, Sales and Marketing Gilead, jounce, oncology, pharma

Gilead and Jounce Therapeutics have come together in a new immuno-oncology partnership potentially worth over $700 million. The primary drive …


Celgene boosts cancer portfolio with deal worth up to $2.5 billion with Jounce Therapeutics

July 19, 2016
Research and Development, Sales and Marketing Celgene, jounce

Celgene has entered into a collaboration with Jounce Therapeutics that will see the pair jointly develop and commercialise Jounce’s lead …

Latest content